Emphysematous pyelonephritis, a rare cause of pneumoperitoneum: a case report and review of literature
© Strofilas et al; licensee BioMed Central Ltd. 2008
Received: 09 June 2008
Accepted: 14 August 2008
Published: 14 August 2008
Emphysematous pyelonephritis is a gas-producing necrotizing bacterial infection that involves the renal parenchyma and perirenal tissue.
We report on a case of a 55 year old Caucasian male with no prior medical history presented with left flank pain and malaise. He was diagnosed with emphysematous pyelonephritis, and was successfully treated in our department. The case is presented along with a literature review.
Prompt diagnosis and early treatment is crucial because of the high rate of mortality. Therapeutic modalities and prognostic factors regarding emphysematous pyelonephritis remain controversial.
The first case of gas-forming renal infection was reported in 1898 by Kelly and MacCallum . Since then many names have been used to describe emphysematous pyelonephritis (EPN) such as renal emphysema, pyelonephritis emphysematousa and pneumonephritis . In 1962 Schultz and Klorfein proposed emphysematous pyelonephritis as the preferred designation name, because it stresses the relationship between acute renal infection and gas formation .
Emphysematous pyelonephritis is a severe, potentially fatal, necrotizing pyelonephritis with a variable clinical picture ranging from mild abdominal pain to septic shock. The majority of cases occur in diabetics with poor glycemic control while a small percentage may be due to urinary tract obstruction [4, 5]. Previous researchers have postulated that vigorous resuscitation and appropriate medical treatment should be followed by immediate nephrectomy [5, 6]. However current advances in treatment, allow patients to be treated with percutaneous drainage in combination with broad spectrum antibiotics [4, 7, 8].
We present a case of emphysematous pyelonephritis in a patient with no prior medical history of diabetes or urinary obstruction that was successfully treated with antibiotics and open drainage.
A 55 year old Caucasian male with no prior medical history, non-smoker, presented to the emergency department due to left flank pain that was located abruptly, 2 days ago, with progressive aggravation and malaise.
Initial vital signs showed a temperature of 40°C, heart rate of 88 beats per minute, blood pressure of 120/80 mmHg and a respiratory rate of 20 breaths per minute. Physical examination on admission revealed an ill-appearing man, with left-sided costovertebral angle tenderness; he appeared confused and slightly agitated. He had been anuric for 12 hours prior to admission, providing 500 ml of urine after catheterization of his urinary bladder.
Laboratory tests revealed a white blood cell count (WBC) count of 12,100/mm3 with 76% granulocytes, hemoglobin of 15.7 g/dl, platelet count of 173,010/mm3, creatinine level of 1.3 mg/dl and urea of 118 mg/dl. Urine analysis demonstrated numerous WBC and gram negative bacilli.
At laparotomy an extra-peritoneal abscess, located in the left perinephric area, was found and treated with drainage. The patient was treated with intravenous ticarcillin – clavulanic acid (5a+0.2b) g/vial (TIMENTIN/Smith Kline Beecham, Athens, Greece), 4 times per day, for 12 days. Cultures from the blood and urine sample showed the offensive microorganism to be Escherichia coli. The patient had an uneventful postoperative course and during his hospital stay his symptoms resolved completely.
Emphysematous pyelonephritis has been defined as a necrotizing infection of the renal parenchyma and its surrounding areas that results in the presence of gas in the renal parenchyma, collecting system or perinephric tissue . More than 90% of cases occur in diabetics with poor glycemic control. Other predisposing factors include urinary tract obstruction, polycystic kidneys, end stage renal disease and immunosupression [4, 5].
The pathogenesis of EPN remains unclear however four factors have been implicated, including gas-forming bacteria, high tissue glucose level (favoring rapid bacterial growth), impaired tissue perfusion (diabetic nephropathy leads to further compromise regional oxygen delivery in the kidney resulting in tissue ischemia and necrosis; nitrogen released during tissue necrosis) and a defective immune response due to impaired vascular supply. Intrarenal thrombi and renal infarctions have been claimed to be predisposing factors in non-diabetic patients [4, 5].
The main bacteria causing emphysematous pyelonephritis are the classical germs of urinary tract infection. The most common is Escherichia coli. Other bacteria include Klebsiella pneumoniae, Proteus mirabilis and Pseudomonas aeruginosa [4–7]. Anaerobic infection is extremely uncommon .
The mean patient age is 55 years old. Women outnumbered men probably due to their increased susceptibility to urinary tract infections. The left kidney was more frequently involved than the right one .
The clinical manifestations of EPN appear to be similar to those encountered in classical cases of upper urinary tract infections. According to Huang and Tseng  fever was encountered in 79% of the patients, abdominal or back pain in 71%, nausea and vomiting in 17%, lethargy and confusion in 19%, dyspnea in 13% and shock in 29%. Laboratory testing revealed elevated glycosylated hemoglobin in 72%, leukocytosis in 67%, thrombocytopenia in 46% and pyuria in 79%. This data comes to agreement with those generally reported in the literature [5–12].
Various imaging techniques can be used to detect gas within the genitourinary system. Ultrasound is insensitive for the diagnosis of renal gas, but useful in diagnosing urinary tract obstruction. It is also a readily available, non-invasive method that is quite useful in the hands of experienced practitioners . Non-contrast CT scan remains the diagnostic method of choice. In addition to showing the presence of gas, it defines the extent of the infection and can diagnose any obstruction [4, 5].
Two staging systems, based on CT findings, have been proposed for prognostic and therapeutic reasons. Wan et al  described two types. Type I included patients showing parenchymal destruction with streaky or mottled gas but with no fluid collection. These patients had a mortality rate of 69%. Type II patients had renal or perirenal fluid collections that contained bubbly or loculated gas or gas within the collecting system. The mortality rate in this group was 18%. Huang and Tseng et al defined four classes. In class1, gas was limited in the collecting system. In class2, gas was in the renal parenchyma without extension to the extrarenal space. In class 3A, gas extended to the perinephric space, in class 3B, to the pararenal space. Class 4, was referred to bilateral emphysematous pyelonephritis or a solitary kidney with emphysematous pyelonephritis [4, 8].
The treatment of EPN remains controversial. According to some investigators [5, 6] vigorous resuscitation, administration of antimicrobial agents and control of blood glucose and electrolytes should be followed by immediate nephrectomy. Huang and Tseng et al [4, 8] proposed certain therapeutic modalities based upon their radiological classification system. Localized emphysematous pyelonephritis (class 1 and 2) is confronted by antibiotic treatment, combined with CT-guided percutaneous drainage. For extensive EPN (classes 3 and 4) without signs of organ dysfunction antibiotic therapy combined with percutaneous catheter placement should be attempted. However nephrectomy should be promptly attempted in patients with extensive EPN and signs of organ dysfunction.
Risk factors indicating poor prognosis include thrombocytopenia, acute renal failure, disturbance of consciousness and shock [4, 14]. However Falagas et al  suggested that increased serum creatinine level, disturbance of consciousness and hypotension may need further research to confirm their potential use as risk factors for fatal outcome. Furthermore their meta-analysis suggest that conservative treatment alone is a risk factor for adverse outcome, although one must take into consideration the different scheme, used by the authors of the studies included, when defining terms such as conservative treatment.
In summary, in high risk groups, such as diabetics, presenting with persistent upper urinary tract infection semiology that does not resolve with proper antibiotic treatment, the presence of a severe renal infection such as EPN should be considered. CT-guided percutaneous drainage or open drainage, along with antibiotic treatment, may be a reasonable alternative to nephrectomy. However surgical intervention should not be delayed in patients with extensive disease or in those who do not substantially improve after appropriate medical treatment and drainage.
"Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal."
white blood cell count
- Michaeli J, Mogle P, Perlberg S, Heiman S, Caine M: Emphysematous pyelonephritis. J Urol. 1984, 131 (2): 203-8.PubMedGoogle Scholar
- Schultz EH, Klorfein EH: Emphysematous pyelonephritis. J Urol. 1962, 87: 762-6.PubMedGoogle Scholar
- Huang Kelly HA, MacCallum WG: Pneumaturia. JAMA. 1898, 31: 375-381.View ArticleGoogle Scholar
- JJ Tseng CC: Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis. Arch Intern Med. 160 (6): 797-805. 2000 Mar 27
- Shokeir AA, El-Azab M, Mohsen T, El-Diasty T: Emphysematous pyelonephritis: a 15-year experience with 20 cases. Urology. 1997, 49 (3): 343-6. 10.1016/S0090-4295(96)00501-8.View ArticlePubMedGoogle Scholar
- Ahlering TE, Boyd SD, Hamilton CL, Bragin SD, Chandrasoma PT, Lieskovsky G, Skinner DG: Emphysematous pyelonephritis: a 5-year experience with 13 patients. J Urol. 1985, 134 (6): 1086-8.PubMedGoogle Scholar
- Wang JM, Lim HK, Pang KK: Emphysematous pyelonephritis. Scand J Urol Nephrol. 2007, 41 (3): 223-9. 10.1080/00365590601017451.View ArticlePubMedGoogle Scholar
- Tseng CC, Wu JJ, Wang MC, Hor LI, Ko YH, Huang JJ: Host and bacterial virulence factors predisposing to emphysematous pyelonephritis. Am J Kidney Dis. 2005, 46 (3): 432-9. 10.1053/j.ajkd.2005.05.019.View ArticlePubMedGoogle Scholar
- Christensen J, Bistrup C: Case report: emphysematous pyelonephritis caused by clostridium septicum and complicated by a mycotic aneurysm. Br J Radiol. 1993, 66 (789): 842-3.View ArticlePubMedGoogle Scholar
- Mallet M, Knockaert DC, Oyen RH, Van Poppel HP: Emphysematous pyelonephritis: no longer a surgical disease?. Eur J Emerg Med. 2002, 9 (3): 266-9. 10.1097/00063110-200209000-00012.View ArticlePubMedGoogle Scholar
- Stone SC, Mallon WK, Childs JM, Docherty SD: Emphysematous pyelonephritis: clues to rapid diagnosis in the Emergency Department. J Emerg Med. 2005, 28 (3): 315-9. 10.1016/j.jemermed.2004.07.015.View ArticlePubMedGoogle Scholar
- Vetere NS, Monti J, Gutman D: A case report of emphysematous pyelonephritis secondary to ureteral obstruction in a non-diabetic patient. Am J Emerg Med. 2006, 24 (6): 749-50. 10.1016/j.ajem.2006.02.018.View ArticlePubMedGoogle Scholar
- Wan YL, Lee TY, Bullard MJ, Tsai CC: Acute gas-producing bacterial renal infection: correlation between imaging findings and clinical outcome. Radiology. 1996, 198 (2): 433-8.View ArticlePubMedGoogle Scholar
- Wan YL, Lo SK, Bullard MJ, Chang PL, Lee TY: Predictors of outcome in emphysematous pyelonephritis. J Urol. 1998, 159 (2): 369-73. 10.1016/S0022-5347(01)63919-3.View ArticlePubMedGoogle Scholar
- Falagas ME, Alexiou VG, Giannopoulou KP, Siempos II: Risk factors for mortality in patients with emphysematous pyelonephritis: a meta-analysis. J Urol. 2007, 178 (3 Pt 1): 880-5. 10.1016/j.juro.2007.05.017. quiz 1129View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.